Skip to main content

Table 4 Tumor response

From: Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study

 

≤ 75 years

>75 years

Total

Full analysis set

(no. of patients (%))

n

704

533

1237

CR

54 (8 %)

24 (5 %)

78 (6 %)

PR

215 (31 %)

145 (27 %)

360 (29 %)

SD

232 (33 %)

165 (31 %)

397 (32 %)

PD

98 (14 %)

94 (18 %)

192 (16 %)

Insufficient assessment

105 (15 %)

105 (20 %)

210 (17 %)